FdaApplication
NDA 012359
Identifiers
- fda_app_no: NDA012359
Properties
| Property | Value |
|---|---|
| applicant_name | SHIRE DEVELOPMENT INC |
| application_type | NDA |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| SALUTENSIN | HYDROFLUMETHIAZIDE; RESERPINE | 50MG;0.125MG | TABLET;ORAL |
| SALUTENSIN-DEMI | HYDROFLUMETHIAZIDE; RESERPINE | 25MG;0.125MG | TABLET;ORAL |
2 products